Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Connect Biopharma Holdings (CNTB) Prepaid Assets (2023 - 2025)

Historic Prepaid Assets for Connect Biopharma Holdings (CNTB) over the last 3 years, with Q3 2025 value amounting to $7.8 million.

  • Connect Biopharma Holdings' Prepaid Assets changed N/A to $7.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.8 million, marking a year-over-year change of. This contributed to the annual value of $2.5 million for FY2024, which is 4202.35% down from last year.
  • Latest data reveals that Connect Biopharma Holdings reported Prepaid Assets of $7.8 million as of Q3 2025.
  • In the past 5 years, Connect Biopharma Holdings' Prepaid Assets ranged from a high of $7.8 million in Q3 2025 and a low of $2.5 million during Q4 2024
  • For the 3-year period, Connect Biopharma Holdings' Prepaid Assets averaged around $4.9 million, with its median value being $4.2 million (2023).
  • Within the past 5 years, the most significant YoY rise in Connect Biopharma Holdings' Prepaid Assets was 4202.35% (2024), while the steepest drop was 4202.35% (2024).
  • Connect Biopharma Holdings' Prepaid Assets (Quarter) stood at $4.2 million in 2023, then plummeted by 42.02% to $2.5 million in 2024, then surged by 216.52% to $7.8 million in 2025.
  • Its Prepaid Assets stands at $7.8 million for Q3 2025, versus $6.0 million for Q2 2025 and $3.8 million for Q1 2025.